Characterization of a multidrug-resistant chronic myeloid leukemia cell line presenting multiple resistance mechanisms (Q39121828)

9 September 2017

title

Characterization of a multidrug-resistant chronic myeloid leukemia cell line presenting multiple resistance mechanisms (English)

1 reference

9 September 2017

main subject

chronic myeloid leukemia

0 references

multiple drug resistance

1 reference

1 reference

3

1 reference

9 September 2017

author name string

Nathalia Daflon-Yunes

1

1 reference

9 September 2017

Flavio Eduardo Pinto-Silva

2

1 reference

9 September 2017

Bruna Fortunato Novis

4

1 reference

9 September 2017

Tandressa Berguetti

5

1 reference

9 September 2017

Raphael Rodrigues Soares Lopes

6

1 reference

9 September 2017

Carla Polycarpo

7

1 reference

9 September 2017

Vivian M Rumjanek

8

1 reference

9 September 2017

publication date

23 July 2013

1 reference

Molecular and Cellular Biochemistry

9 September 2017

published in

1 reference

9 September 2017

volume

383

1 reference

9 September 2017

issue

1-2

1 reference

9 September 2017

page(s)

123-135

1 reference

The development of imatinib as a therapeutic agent for chronic myeloid leukemia

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Interaction of imatinib mesilate with human P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Functional consequence of MDR1 expression on imatinib intracellular concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Drug transporters and imatinib treatment: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

A multidrug resistance transporter from human MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Recent developments in drug resistance mechanism in chronic myeloid leukemia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Multidrug resistance in tumour cells: characterization of the multidrug resistant cell line K562-Lucena 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Advances in the treatment of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Imatinib resistance in multidrug-resistant K562 human leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Anti-proliferative effect of the abl tyrosine kinase inhibitor STI571 on the P-glycoprotein positive K562/ADM cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

RNAi-mediated knockdown of P-glycoprotein using a transposon-based vector system durably restores imatinib sensitivity in imatinib-resistant CML cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Is resistance useless? Multidrug resistance and collateral sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Verapamil and its derivative trigger apoptosis through glutathione extrusion by multidrug resistance protein MRP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Verapamil hypersensitivity of vincristine resistant Chinese hamster ovary cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Cell death induced by the Fas/Fas ligand pathway and its role in pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

CD69 and regulation of the immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Pomolic acid-induced apoptosis in cells from patients with chronic myeloid leukemia exhibiting different drug resistance profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Variation of MDR proteins expression and activity levels according to clinical status and evolution of CML patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Sequential emergence of MRP- and MDR1-gene over-expression as well as MDR1-gene translocation in homoharringtonine-selected K562 human leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Pathway-specific differences between tumor cell lines and normal and tumor tissue cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

A Mechanism for P-Glycoprotein-Mediated Apoptosis As Revealed by Verapamil Hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Iodination of verapamil for a stronger induction of death, through GSH efflux, of cancer cells overexpressing MRP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Identification of xanthones as selective killers of cancer cells overexpressing the ABC transporter MRP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Collateral sensitivity as a strategy against cancer multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Transport of phosphatidylserine via MDR1 (multidrug resistance 1)P-glycoprotein in a human gastric carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Retention of the mitochondrial probe rhodamine 123 in normal lymphocytes and leukemic cells in relation to the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Drug resistance does not correlate with resistance to Fas-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Impairment of Fas-antigen expression in adriamycin-resistant but not TNF-resistant MCF7 tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1761-0

The molecular biology of chronic myeloid leukemia.

21 January 2018

1 reference

12 December 2020

Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance.

1 reference

12 December 2020

Contrasting features of MDR phenotype in leukemias by using two fluorochromes: implications for clinical practice

1 reference

12 December 2020

Survivin and P-glycoprotein are associated and highly expressed in late phase chronic myeloid leukemia.

1 reference

12 December 2020

Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids

1 reference

12 December 2020

Triggering noncycling hematopoietic progenitors and leukemic blasts to proliferate increases anthracycline retention and toxicity by downregulating multidrug resistance

1 reference

12 December 2020

Bcr-abl translocation can occur during the induction of multidrug resistance and confers apoptosis resistance on myeloid leukemic cell lines

1 reference

12 December 2020

10.1007/S11010-013-1761-0

Identifiers

DOI

1 reference

9 September 2017

1 reference